JP2020517306A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020517306A5 JP2020517306A5 JP2020507985A JP2020507985A JP2020517306A5 JP 2020517306 A5 JP2020517306 A5 JP 2020517306A5 JP 2020507985 A JP2020507985 A JP 2020507985A JP 2020507985 A JP2020507985 A JP 2020507985A JP 2020517306 A5 JP2020517306 A5 JP 2020517306A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- antibody
- amino acid
- acid sequence
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023024232A JP2023078133A (ja) | 2017-04-21 | 2023-02-20 | 糖尿病関連用途のための方法及び抗体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762488346P | 2017-04-21 | 2017-04-21 | |
| US62/488,346 | 2017-04-21 | ||
| PCT/US2018/027856 WO2018195008A1 (en) | 2017-04-21 | 2018-04-17 | Methods and antibodies for diabetes-related applications |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023024232A Division JP2023078133A (ja) | 2017-04-21 | 2023-02-20 | 糖尿病関連用途のための方法及び抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020517306A JP2020517306A (ja) | 2020-06-18 |
| JP2020517306A5 true JP2020517306A5 (enExample) | 2021-05-27 |
| JP7303182B2 JP7303182B2 (ja) | 2023-07-04 |
Family
ID=63856388
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020507985A Active JP7303182B2 (ja) | 2017-04-21 | 2018-04-17 | 糖尿病関連用途のための方法及び抗体 |
| JP2023024232A Pending JP2023078133A (ja) | 2017-04-21 | 2023-02-20 | 糖尿病関連用途のための方法及び抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023024232A Pending JP2023078133A (ja) | 2017-04-21 | 2023-02-20 | 糖尿病関連用途のための方法及び抗体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11866506B2 (enExample) |
| EP (1) | EP3612625A4 (enExample) |
| JP (2) | JP7303182B2 (enExample) |
| AU (1) | AU2018255244A1 (enExample) |
| SG (1) | SG11201909708VA (enExample) |
| TW (1) | TW201902927A (enExample) |
| WO (1) | WO2018195008A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201909708VA (en) | 2017-04-21 | 2019-11-28 | Mellitus Llc | Methods and antibodies for diabetes-related applications |
| CN112924682B (zh) * | 2019-12-05 | 2023-02-10 | 张曼 | 尿液纤维蛋白原α链蛋白及其多肽片段在正常妊娠中的应用 |
| US11303968B1 (en) | 2020-10-09 | 2022-04-12 | Hulu, LLC | Personalized ranking of entities in an electronic programming guide for live television |
| CN112904009B (zh) * | 2021-02-19 | 2022-03-18 | 山东莱博生物科技有限公司 | 一种检测糖基化cd59的磁性微球检测试剂盒及其应用 |
| WO2022241236A2 (en) * | 2021-05-13 | 2022-11-17 | Mellitus, Llc | Methods and reagents for protein analysis |
| CN115290609B (zh) * | 2021-12-22 | 2024-08-09 | 温州医科大学 | 快速检测肝素的试剂及检测方法 |
| CN115144348B (zh) * | 2022-07-06 | 2025-02-14 | 浙江伊利康生物技术有限公司 | 糖化白蛋白检测试剂盒、制备方法及其应用方法 |
| WO2024166110A1 (en) * | 2023-02-12 | 2024-08-15 | Hadasit Medical Research Services And Development Ltd. | Targeted reduction of cd59 for use in treating disease |
| US20240407735A1 (en) * | 2023-06-07 | 2024-12-12 | Dexcom, Inc. | Systems and methods for diabetes prediction |
| JP2025026011A (ja) | 2023-08-10 | 2025-02-21 | 株式会社ツジデン | 光集光補助フィルム、該光集光補助フィルムを搭載するエッジライト型バックライトユニット、及び該エッジライト型バックライトを搭載する液晶表示装置。 |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4208479A (en) | 1977-07-14 | 1980-06-17 | Syva Company | Label modified immunoassays |
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| FR2619568B1 (fr) | 1987-08-21 | 1989-07-07 | Centre Nat Rech Scient | Polymeres derives du polystyrene, leurs procedes de preparation et leurs applications pour l'analyse et la purification de molecules d'origine biologique |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
| GB9110962D0 (en) | 1991-05-21 | 1991-07-10 | Ici Plc | Process |
| ATE207080T1 (de) | 1991-11-25 | 2001-11-15 | Enzon Inc | Multivalente antigen-bindende proteine |
| EP0563475B1 (en) | 1992-03-25 | 2000-05-31 | Immunogen Inc | Cell binding agent conjugates of derivatives of CC-1065 |
| AU670108B2 (en) | 1992-09-11 | 1996-07-04 | Becton Dickinson & Company | Improved antibodies to plasmodium falciparum |
| US5670377A (en) | 1996-03-14 | 1997-09-23 | Sansum Medical Research Foundation | Method of diagnosing gestational diabetes |
| US6348584B1 (en) | 1996-10-17 | 2002-02-19 | John Edward Hodgson | Fibronectin binding protein compounds |
| EP1958962A3 (en) | 1997-06-12 | 2013-05-01 | Novartis International Pharmaceutical Ltd. | Artificial antibody polypeptides |
| US6835545B2 (en) | 2000-05-08 | 2004-12-28 | President And Fellows Of Harvard College | Methods, products and treatments for diabetes |
| US7439330B2 (en) * | 2000-05-08 | 2008-10-21 | President And Fellows Of Harvard College | Anti-glycated CD59 antibodies and uses thereof |
| US7754208B2 (en) | 2001-01-17 | 2010-07-13 | Trubion Pharmaceuticals, Inc. | Binding domain-immunoglobulin fusion proteins |
| GB0124317D0 (en) | 2001-10-10 | 2001-11-28 | Celltech R&D Ltd | Biological products |
| US7460960B2 (en) | 2002-05-10 | 2008-12-02 | Epitome Biosystems, Inc. | Proteome epitope tags and methods of use thereof in protein modification analysis |
| AU2003298650B2 (en) | 2002-11-15 | 2010-03-11 | Musc Foundation For Research Development | Complement receptor 2 targeted complement modulators |
| WO2004058178A2 (en) | 2002-12-23 | 2004-07-15 | Schering Corporation | Uses of mammalian cytokine; related reagents |
| GB2409456B (en) | 2003-10-30 | 2006-01-04 | Proimmune Ltd | Oligomeric receptor ligand pair member complexes |
| WO2006009533A1 (en) | 2004-06-17 | 2006-01-26 | President And Fellows Of Harvard College | Anti-glycated cd59 antibodies and uses thereof |
| US7632924B2 (en) | 2004-06-18 | 2009-12-15 | Ambrx, Inc. | Antigen-binding polypeptides and their uses |
| US7833725B2 (en) | 2005-01-06 | 2010-11-16 | President And Fellows Of Harvard College | Mass spectrometric methods and products |
| US7906625B2 (en) * | 2005-01-24 | 2011-03-15 | Amgen Inc. | Humanized anti-amyloid antibody |
| CA2606018A1 (en) | 2005-04-28 | 2006-11-02 | Ventana Medical Systems, Inc. | Nanoparticle conjugates |
| EP1948691A1 (en) | 2005-11-17 | 2008-07-30 | Millennium Pharmaceuticals, Inc. | HUMANIZED IMMUNOGLOBULIN REACTIVE WITH a4ß7INTEGRIN |
| US20100331200A1 (en) | 2006-03-31 | 2010-12-30 | Gordon Neal F | Post translational modification pattern analysis |
| WO2007133623A2 (en) | 2006-05-10 | 2007-11-22 | Biopeptides Corporation | Peptide diagnostic agent for lyme disease |
| EP2087007A2 (en) | 2006-11-09 | 2009-08-12 | Irm Llc | Agonist trkb antibodies and uses thereof |
| WO2008137165A1 (en) | 2007-05-07 | 2008-11-13 | President And Fellows Of Harvard College | Anti-glycated cd59 antibodies and uses thereof |
| CN101965365A (zh) | 2007-10-19 | 2011-02-02 | 伊缪纳斯制药株式会社 | 能够特异性结合Aβ寡聚体的抗体及其应用 |
| UA104132C2 (en) * | 2007-11-13 | 2014-01-10 | Тева Биофармасьютикалз Юесей, Инк. | Humanized antibodies against tl1a |
| AU2011261396B2 (en) | 2010-06-02 | 2015-11-05 | Dana-Farber Cancer Institute, Inc. | Humanized monoclonal antibodies and methods of use |
| US9068006B2 (en) | 2010-08-25 | 2015-06-30 | President And Fellows Of Harvard College | Glycated CD59 peptides, their preparation, and uses thereof |
| BR112013020274A2 (pt) | 2011-02-10 | 2016-11-22 | Harvard College | substitutos de proteínas pós-traducionalmente modificadas e usos dos mesmos |
| EP2543679A1 (en) | 2011-07-08 | 2013-01-09 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Antibodies for the treatment and prevention of thrombosis |
| US20140322723A1 (en) | 2011-11-22 | 2014-10-30 | President and Dellows of Harvard College | Diabetes diagnosis through the detection of glycated proteins in urine |
| JP2016500704A (ja) | 2012-11-06 | 2016-01-14 | スカラー ロック インコーポレイテッドＳｃｈｏｌａｒ Ｒｏｃｋ，Ｉｎｃ． | 細胞シグナル伝達を変調するための組成物及び方法 |
| CA2896058A1 (en) * | 2012-12-24 | 2014-07-03 | Abbvie Inc. | Prolactin receptor binding proteins and uses thereof |
| EP3620793A1 (en) | 2013-12-03 | 2020-03-11 | President And Fellows Of Harvard College | Methods and reagents for the assessment of gestational diabetes |
| SG11201909708VA (en) | 2017-04-21 | 2019-11-28 | Mellitus Llc | Methods and antibodies for diabetes-related applications |
-
2018
- 2018-04-17 SG SG11201909708V patent/SG11201909708VA/en unknown
- 2018-04-17 WO PCT/US2018/027856 patent/WO2018195008A1/en not_active Ceased
- 2018-04-17 US US16/606,887 patent/US11866506B2/en active Active
- 2018-04-17 JP JP2020507985A patent/JP7303182B2/ja active Active
- 2018-04-17 AU AU2018255244A patent/AU2018255244A1/en not_active Abandoned
- 2018-04-17 EP EP18788604.9A patent/EP3612625A4/en not_active Withdrawn
- 2018-04-17 TW TW107113049A patent/TW201902927A/zh unknown
-
2023
- 2023-02-20 JP JP2023024232A patent/JP2023078133A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020517306A5 (enExample) | ||
| JP7344801B2 (ja) | グリア原線維性酸性タンパク質（ｇｆａｐ）及び／又はユビキチンカルボキシ末端ヒドロラーゼｌ１（ｕｃｈ－ｌ１）を使用する、整形外科損傷を負っており、軽度外傷性脳損傷（ｔｂｉ）などの頭部への損傷を負ったか又は負った可能性がある対象についての診断及び査定の一助となるための方法 | |
| JP7080899B2 (ja) | 同じヒト対象に由来する少なくとも２つの試料に対して早期バイオマーカーを使用する、外傷性脳損傷の超急性の診断及び決定の一助となるための方法 | |
| JP2021505844A (ja) | Ｇｆａｐとｕｃｈ−ｌ１との組合せを使用する、ヒト対象における外傷性脳損傷を診断及び査定する一助となるための方法 | |
| CN110383068A (zh) | 评估患者样品中uch-l1状态的改进方法 | |
| JP2020521951A (ja) | 早期バイオマーカーを使用する、頭部への損傷を負ったヒト対象又は負った可能性があるヒト対象に対して、イメージングを実施するかどうかの決定の一助となるための方法 | |
| JP2020512550A (ja) | 早期バイオマーカーであるユビキチンカルボキシ末端ヒドロラーゼｌ１を使用する、ヒト対象における外傷性脳損傷の程度の診断及び決定の一助となるための方法 | |
| JP2021509475A (ja) | 外傷性脳損傷を診断及び査定するための、新規のバイオマーカー及び方法 | |
| EP3248001B1 (en) | Diagnostic devices and methods for mitigating hook effect and use thereof | |
| CN110286234A (zh) | 尿液中妊娠糖尿病的蛋白质标志物及其在早期诊断中的用途 | |
| JP7592412B2 (ja) | 魚介類アレルギーの診断の方法及び製品 | |
| RU2008103608A (ru) | Выявление антигена-мишени вне зависимости от присутствия или отсутствия соответствующего терапевтического антитела | |
| RU2012120706A (ru) | Диагностические и терапевтические способы | |
| RU2014140427A (ru) | Способ прогнозирования риска развития у субъекта сахарного диабета и/или метаболического синдрома или для диагностирования метаболического синдрома у субъекта | |
| JP7454945B2 (ja) | 血液中のユビキチンカルボキシ末端ヒドロラーゼｌ１レベルを測定するための、改善された方法 | |
| JP7036751B2 (ja) | アポトーシスのモニタリングのための、ガンマ－グルタミル－ｌ－イプシロン－リジンに特異的なモノクローナル抗体 | |
| KR20170093141A (ko) | 데옥시하이푸신·신타제 유전자를 지표로서 사용하는 동맥 경화 및 암의 검출 방법 | |
| JP7062291B2 (ja) | アレルギー発症リスクを予測するためのデータを収集する方法 | |
| JP2025503439A (ja) | 血液試料におけるｕｃｈ－ｌ１、ｇｆａｐ及び他のバイオマーカーを決定するためのシステム及び方法 | |
| JP7778702B2 (ja) | 腸管バリア機能障害および／または肝硬変の検出 | |
| CN110275014B (zh) | 一种术中快速鉴别甲状腺乳头状癌颈淋巴结转移的方法 | |
| TW202235878A (zh) | 一種小鼠抗人源缺陷ＩｇＡ１之單株抗體及其製備方法和用途 | |
| AU2014351090A1 (en) | Biomarker for cardiac disorders | |
| KR102882391B1 (ko) | 새우에 대한 아나필락시스 진단용 조성물 | |
| CN120943957A (zh) | 一种凝溶胶蛋白单克隆抗体及其应用 |